Guardant Health, Inc. cash flow to debt ratio of -10.80% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

Guardant Health, Inc.'s free cash flow has increased -15.23% from $-274.94M last year to $-233.07M, signaling increasing performance

Guardant Health, Inc.'s debt to equity ratio is -7.61, signaling that the company spent its equity and risk bankruptcy.

Guardant Health, Inc.'s debt to equity ratio is -7.61, signaling that the company spent its equity and risk bankruptcy.

Guardant Health, Inc. has negative EBITDA, making leverage ratio unreliable

Guardant Health, Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Guardant Health, Inc.'s profit margin has increased (-35.09%) in the last year from -59.05% to -38.33%, signaling increasing performance

Guardant Health, Inc.'s short-term assets of $1.47B exceed its short-term liabilities of $302.73M

Guardant Health, Inc.'s return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

Guardant Health, Inc.'s return on equity of 211.46%, is higher than 15.00%, indicating good performance

Guardant Health, Inc.'s operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

Guardant Health, Inc. had positive net income in only 0 out of 5 years, indicating unstable earnings

Guardant Health, Inc. has negative free cash flow, indicating the company is burning cash rather than generating it

Guardant Health, Inc. has negative free cash flow, indicating cash burn

Guardant Health, Inc.'s yearly earnings has increased -4.61% since last year from $-436.37M to $-416.28M, signaling increasing performance

Guardant Health, Inc.'s yearly revenue has increased 32.88% since last year from $739.02M to $982.02M, signaling increasing performance

ROIC -29.30% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

Guardant Health, Inc.'s 3-year revenue CAGR of 29.75% is positive, indicating growing revenue over the past 3 years

Guardant Health, Inc. had revenue growth in 5 out of 5 years, indicating consistent revenue performance

Guardant Health, Inc. had positive ROE in only 0 out of 5 years, indicating inconsistent returns on equity

Guardant Health, Inc. has insufficient data to evaluate this check.

Guardant Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Guardant Health, Inc. is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

Guardant Health, Inc. has negative or missing EBITDA, making EV/EBITDA ratio unreliable

Guardant Health, Inc. is overvalued relative to its fair value price of -151.81 based on Earnings Fair Value model

Guardant Health, Inc. has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

Guardant Health, Inc. has negative shareholder equity; price-to-book is not meaningful and the check fails

Guardant Health, Inc. has a price-to-sales ratio of 18.67x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue